Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: Comparison with sporadic colonic tumors

American Journal of Clinical Pathology

Volumn 127, Issue 3, 2007, Pages 366-373

  Mikami, Tetuo ^a   Yoshida, Tsutomu ^a   Numata, Yoshiko ^a   Shiraishi, Hiroaki ^a   Araki, Kayo ^a   Guiot, Marie Christine ^b   Jass, Jeremy R ^c   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

E cadherin; hMLH1; Methylation; O6 methylguanine DNA methyltransferase; p16INK4; Tumorigenesis; Ulcerative colitis associated tumor

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN P16INK4A; UVOMORULIN; CADHERIN; CARRIER PROTEIN; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; DYSPLASIA; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ULCERATIVE COLITIS; COLON TUMOR; GENE FREQUENCY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

CADHERINS; CARRIER PROTEINS; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENE FREQUENCY; HUMANS; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 34247891624     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/RFETXN6387KLQ1LD     Document Type: Article

References (29)

1. Benhattar J, Saraga E. Molecular genetics of dysplasia in ulcerative colitis. Eur J Cancer. 1995;31A:1171-1173.
2. Tarmin L, Yin J, Harpaz N, et al. Adenomatous polyposis coli gene mutation in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res. 1995;55:2035-2038.
3. Yoshida T, Mikami T, Mitomi H, et al. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts. J Pathol. 2003;199:166-175.
4. Yoshida T, Haga S, Numata Y, et al. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis. Int J Cancer. 2006;118:1395-1403.
5. Mikami T, Yoshida T, Akino F, et al. Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors: association with survivin and bcl-2. Am J Clin Pathol. 2003;119:723-730.
6. Kip1 expression in ulcerative colitis-associated dysplasia. Pathol Int. 2006;56:10-16.
7. Shih IM, Wang TL, Traverso G, et al. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A. 2001;98:2640-2645.
8. Toyota M, Issa JP. The role of DNA hypermethylation in human neoplasia. Electrophoresis. 2000;21:329-333.
9. INK4a genes in colon cancer. Lab Invest. 2001;81:217-229.
10. Bariol C, Suter C, Cheong K, et al. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol. 2003;162:1361-1371.
11. Lind GE, Thorstensen L, Lovig T, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Available at http://www.molecular-cancer.com/content/3/1/28. Accessed January 12, 2007.
12. Lee S, Hwang KS, Lee HJ, et al. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest. 2004;84:884-893.
13. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837-845.
14. INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998;58:3942-3945.
15. Wheeler JMD, Kim HC, Efstathiou JA, et al. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut. 2001;48:367-371.
16. Issa JPJ, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001;61:3573-3577.
17. Matsumura S, Oue N, Ito R, et al. The promoter methylation status of the DNA repair gene O6-methylguanine-DNA methyltransferase in ulcerative colitis. Virchows Arch. 2003;443:518-523.
18. Jass JR, Sobin LH. Histological classification of intestinal tumours. In: Sobin LH, ed. Histological Typing of Intestinal Tumours. 2nd ed. Berlin, Germany: Springer-Verlag; 1989:5-47. World Health Organization International Histological Classification of Tumours.
19. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93:9821-9826.
20. Kang GH, Lee HJ, Hwang KS, et al. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol. 2003;163:1551-1556.
21. Fleisher AS, Esteller M, Harpaz N, et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res. 2000;60:4864-4868.
22. Katoh M. Epithelial-mesenchymal transition in gastric cancer. Int J Oncol. 2005;27:1677-1683.
23. Schuhmacher C, Becker I, Oswald S, et al. Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations. Virchows Arch. 1999;434:489-495.
24. Whitehall VLJ, Walsh MD, Young J, et al. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res. 2001;61:827-830.
25. Wynter CVA, Kambara T, Walsh MD, et al. DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients. Int J Cancer. 2006;118:907-915.
26. Ohmiya N, Matsumoto S, Yamamoto H, et al. Germline and somatic mutation in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene. 2001;272:301-313.
27. Cannavo E, Marra G, Sabates-Bellver J, et al. Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair. Cancer Res. 2005;65:10759-10766.
28. Toyooka S, Tokumo M, Shigematsu H, et al. Mutational and epigenetic evidence for independent pathways for lung adenocarcinoma arising in smokers and never smokers. Cancer Res. 2006;66:1371-1375.
29. Okayasu I, Hana K, Yoshida T, et al. Significant increase of colonic mutated crypts in ulcerative colitis correlatively with duration of illness. Cancer Res. 2002;62:2236-2238.